Merck & Co. Long-term debt interest payments - 2025 increased by 45.5% to $1.60B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 45.5%, from $1.10B to $1.60B. Over 4 years (FY 2021 to FY 2025), Long-term debt interest payments - 2025 shows an upward trend with a 20.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Higher payments indicate a larger debt burden, potentially reducing free cash flow available for dividends or R&D.
This represents the contractual interest obligations due on long-term debt instruments for the specified calendar year....
Standardized across all debt-issuing companies; peers with similar credit ratings should have comparable interest expense profiles.
long_term_debt_interest_payments_2025| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $771.00M | $751.00M | $1.00B | $1.10B | $1.60B |
| QoQ Change | — | -2.6% | +33.2% | +10.0% | +45.5% |
| YoY Change | — | -2.6% | +33.2% | +10.0% | +45.5% |